Literature DB >> 22036030

Pharmacokinetics and metabolism of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat, dog, and man.

K Ubukata1, A Nakayama, R Mihara.   

Abstract

The pharmacokinetics and metabolism of advantame were evaluated in rats, dogs, and humans. The oral pharmacokinetic studies using (14)C-advantame showed that advantame undergoes rapid but incomplete absorption, with an oral bioavailability of total radioactivity in the range of 4-23%. Data indicated that absorption was mainly as ANS9801-acid (de-esterified advantame), which was formed in the gastrointestinal tract as a result of the hydrolysis of the methyl ester group of the parent compound. In the dog, plasma ANS9801-acid was present largely in the form of an unidentified conjugate. Advantame (chiefly in the form of metabolites) was mainly excreted in the feces in rats, dogs, and humans (>80% in each species), with urinary excretion representing a minor route. The predominant metabolite of (14)C-advantame detected in the feces and the urine of rats, dogs, and humans was ANS9801-acid, with lower amounts of 3-[3-hydroxy-4-methoxyphenyl]-1-propylamine (termed HU-1) or N-(3-(3-hydroxy-4-methoxy phenyl))propyl-L-aspartic acid (termed HF-1) present, as well as other minor metabolites and areas of indistinct radioactivity. ANS9801-acid, HU-1, and HF-1 were detected and identified in the urine of rats, humans, and dogs, while ANS9801-acid and HF-1 were identified in the feces of humans and dogs. In the feces of rats, in addition to ANS9801-acid, other additional metabolites were detected, including demethylated ANS9801-acid (designated as RF-1) and another unidentified metabolite (designated as RF-2). Overall, the data show generally similar pharmacokinetics of advantame and ANS9801-acid in animals and in humans and close similarity with neotame. Metabolites of advantame that occur in humans are also found in the 2 species utilized in the toxicology studies, and the metabolism studies support the interpretation of safety data from studies conducted in rats and dogs.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036030     DOI: 10.1016/j.fct.2011.06.042

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

1.  Interactions of Non-Nutritive Artificial Sweeteners with the Microbiome in Metabolic Syndrome.

Authors:  Valerie Harrington; Lilian Lau; Alexander Crits-Christoph; Jotham Suez
Journal:  Immunometabolism       Date:  2022-04-18

Review 2.  Biomarkers of intake for coffee, tea, and sweetened beverages.

Authors:  Joseph A Rothwell; Francisco Madrid-Gambin; Mar Garcia-Aloy; Cristina Andres-Lacueva; Caomhan Logue; Alison M Gallagher; Carina Mack; Sabine E Kulling; Qian Gao; Giulia Praticò; Lars O Dragsted; Augustin Scalbert
Journal:  Genes Nutr       Date:  2018-07-04       Impact factor: 5.523

3.  Purification, characterization, and identification of 3-hydroxy-4-methoxy benzal acrolein-an intermediate of synthesizing advantame.

Authors:  Bo-Ru Chen; Qiang Liu; Huan Wang; Zi-Yuan Gao; Azhari Siddeeg; Si-Ming Zhu
Journal:  Food Sci Nutr       Date:  2020-01-01       Impact factor: 2.863

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.